ID Clinic Arkadiusz Pisula

Mysłowice 41-400

1 studies enrolling now · 5 studies all time

What they study most

Alpha1-Antitrypsin Deficiency, Nonalcoholic Steatohepatitis, Obesity, Overweight, Primary Biliary Cholangitis, Primary Biliary Cirrhosis

Studies at this site

• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
• Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
• A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight — Withdrawn before enrolling
• Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early